Diagnostic accuracy of image-guided biopsies in small (<4 cm) renal masses with implications for active surveillance: a systematic review of the evidence
- PMID: 29888978
- PMCID: PMC6350473
- DOI: 10.1259/bjr.20170761
Diagnostic accuracy of image-guided biopsies in small (<4 cm) renal masses with implications for active surveillance: a systematic review of the evidence
Abstract
Objective:: To determine the safety and diagnostic accuracy of renal tumour biopsies in a defined population of small renal masses (SRMs) only <4 cm using 3 × 2 table, intention to diagnose approach. 3 × 2 table approach examines indeterminate results as a separate category rather than pushing these through traditional 2 × 2 table (four-cell matrix) approach.
Methods:: A highly sensitive search was performed in the Cochrane Library, Database of Abstracts of Reviews of Effects; MEDLINE and MEDLINE in Process, EMBASE and conference proceedings (1966-2016) for the acquisition of data on the diagnostic accuracy and complications of RTB in patients with SRM <4 cm. Methodological quality and risk of bias was assessed using QUADAS-2. Test characteristics were calculated using conventional 2 × 2 contingency table analysis excluding non-diagnostic biopsies, and an intention-to-diagnose approach with a 3 × 2 table for pooled estimates of the sensitivity and specificity.
Results:: A total of 20 studies were included with a total sample size of 974. The pooled estimates for sensitivity and specificity of RTB based upon univariate analysis using 2 × 2 table observed sensitivity 0.952 [confidence interval (CI) 0.908-0.979] and specificity 0.824 (CI 0.566-0.962). Using the 3 × 2 table and intention-to-diagnose principle, sensitivity 0.947 (CI 0.925-0.965) and specificity 0.609 (CI 0.385-0.803) decreased.
Conclusion:: RTB in SRMs (<4 cm) is associated with a high diagnostic sensitivity but poor specificity when non-diagnostic results are included by a 3 × 2 table for analysis (intention to diagnose approach). Risk of non-diagnostic results and poor quality of research need addressing through future studies, preferably by a well-designed prospective study appropriately powered for diagnostic accuracy using valid reference standards.
Advances in knowledge:: A comprehensive synthesis of literature on image-guided biopsies in SRMs using a different methodology and study design.
Figures




Similar articles
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments.Cochrane Database Syst Rev. 2022 Jul 11;7(7):CD013172. doi: 10.1002/14651858.CD013172.pub2. Cochrane Database Syst Rev. 2022. PMID: 35815652 Free PMC article.
-
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2. Cochrane Database Syst Rev. 2022. PMID: 35320584 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2. Cochrane Database Syst Rev. 2022. PMID: 35233774 Free PMC article.
Cited by
-
Radiomics Machine Learning Analysis of Clear Cell Renal Cell Carcinoma for Tumour Grade Prediction Based on Intra-Tumoural Sub-Region Heterogeneity.Cancers (Basel). 2024 Apr 10;16(8):1454. doi: 10.3390/cancers16081454. Cancers (Basel). 2024. PMID: 38672536 Free PMC article.
-
MRI-guided thoraco-abdominal percutaneous needle biopsy: our initial experience.Eur Radiol. 2023 Aug;33(8):5719-5727. doi: 10.1007/s00330-023-09763-1. Epub 2023 May 31. Eur Radiol. 2023. PMID: 37256353
-
Active surveillance of small renal masses.Insights Imaging. 2020 May 5;11(1):63. doi: 10.1186/s13244-020-00853-y. Insights Imaging. 2020. PMID: 32372194 Free PMC article. Review.
-
Small Renal Masses without Gross Fat: What Is the Role of Contrast-Enhanced MDCT?Diagnostics (Basel). 2022 Feb 21;12(2):553. doi: 10.3390/diagnostics12020553. Diagnostics (Basel). 2022. PMID: 35204643 Free PMC article.
-
[Small renal mass: which criteria are decisive for a tumor board?].Urologie. 2024 Dec;63(12):1217-1223. doi: 10.1007/s00120-024-02471-8. Epub 2024 Nov 6. Urologie. 2024. PMID: 39505775 Review. German.
References
-
- Volpe A, Terrone C, Scarpa RM. The current role of percutaneous needle biopsies of renal tumours. Arch Ital Urol Androl 2009; 81: 107–12. - PubMed
-
- Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, et al. . Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol 2010; 184: 1877–81. doi: 10.1016/j.juro.2010.06.105 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical